Gemcitabine in combination with capecitabine in metastatic breast carcinoma: A phase I-II study.

被引：0
|
作者：
Giannessi, PG [1 ]
Martella, F [1 ]
Di Marsico, R [1 ]
Coltelli, L [1 ]
Safina, V [1 ]
Andreuccetti, M [1 ]
Falcone, A [1 ]
机构：
[1] UO Oncol Med, Livorno, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：95S / 95S
页数：1
相关论文
共 50 条
  • [31] Phase I study of sunitinib in combination with gemcitabine/capecitabine for the first-line treatment of metastatic or unresectable renal cell carcinoma.
    Suarez, C.
    Gallardo, E.
    Rodon Ahnert, J.
    Guix, M.
    Bonfill, T.
    Pons, F.
    Beltran, M.
    Moya, I.
    Galtes, S.
    Albanell, J.
    Carles, J.
    Bellmunt, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] Hypofractionated Accelerated Irradiation for Stage I-II Breast Carcinoma: A Phase II Study
    Zygogianni, Anna G.
    Kouvaris, John R.
    Kouloulias, Vassilis
    Armpilia, Christina
    Antypas, Christos
    Vlachos, Lambros
    BREAST JOURNAL, 2010, 16 (03): : 337 - 338
  • [33] Hypofractionated irradiation for stage I-II breast carcinoma. A phase II study
    Zygogianni, A.
    Kouvaris, J.
    Metafa, A.
    Kouloulias, V.
    Gogou, G.
    Antypas, C.
    Armpilia, C.
    Balafouta, M.
    Sandilos, P.
    Vlachos, L.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S266 - S266
  • [34] Phase II study of gemcitabine and capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
    Ahn, JH
    Kim, SB
    Lee, JS
    Kang, YK
    Kim, WK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 101S - 101S
  • [35] Frontline docetaxel (T) capecitabine M combination therapy in patients (pts) with metastatic breast cancer (MBC): A phase II study.
    Chun, JH
    Lee, HG
    Lee, ES
    Kim, E
    Oh, JH
    Ro, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 71S - 71S
  • [36] Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma - A phase I-II clinical investigation
    Gebbia, V
    Mauceri, G
    Fallica, G
    Borsellino, N
    Tirrito, ML
    Testa, A
    Varvara, F
    Colombo, A
    Ferrera, P
    ONCOLOGY, 2002, 63 (01) : 23 - 30
  • [37] Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma
    Waters, JS
    Moss, C
    Pyle, L
    James, M
    Hackett, S
    A'Hern, R
    Gore, M
    Eisen, T
    BRITISH JOURNAL OF CANCER, 2004, 91 (10) : 1763 - 1768
  • [38] Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer
    Welt, A
    von Minckwitz, G
    Oberhoff, C
    Borquez, D
    Schleucher, R
    Loibl, S
    Harstrick, A
    Kaufmann, A
    Seeber, S
    Vanhoefer, U
    ANNALS OF ONCOLOGY, 2005, 16 (01) : 64 - 69
  • [39] Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma
    J S Waters
    C Moss
    L Pyle
    M James
    S Hackett
    R A'Hern
    M Gore
    T Eisen
    British Journal of Cancer, 2004, 91 : 1763 - 1768
  • [40] Phase I/II study of carboplatin, vinorelbine and capecitabine in metastatic breast cancer.
    Rabinowitz, MJ
    Mangalik, A
    Lee, FC
    Cathcart, C
    Verschraegen, C
    Rabinowitz, I
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 57S - 57S
12345